triiodothyronine has been researched along with Cardiomyopathies in 14 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both mitochondrial and microsomal fractions of hyperthyroid rabbit hearts produced 4-5 times as much diacylglycerol 3-phosphate from glycerol 3-phosphate and palmitate as did those of euthyroid hearts." | 3.65 | Phosphatidate phosphohydrolase and palmitoyl-coenzyme A hydrolase in cardiac subcellular fractions of hyperthyroid rabbits and cardiomyopathic hamsters. ( Kako, KJ; Patterson, SD, 1975) |
| "As triiodothyronine (T3) treatment has been shown to normalize depression of cardiac myosin ATPase in diabetic rats, we repeated the study using a combination of T3 (30 micrograms kg-1 day-1 sc daily) and methyl palmoxirate." | 1.27 | Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment. ( McNeill, JH; Tahiliani, AG, 1985) |
| "Reserpine or tyramine treatment resulted in depletion of endogenous cardiac NE in control and diabetic rats." | 1.27 | Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. ( Beamish, RE; Dhalla, KS; Dhalla, NS; Ganguly, PK; Innes, IR, 1987) |
| "In patients with effort syndrome and hyperthyroidism, MTTs were often, but not always shortened below the control values; consequently, in case of associated heart disease, MTT-prolongation may be masked in such instances where hyperthyroidism causes MTT shortening." | 1.25 | [Minimal cardiac transit time in thyroid disorders and in the effort syndrome]. ( Becker, V; Feinendegen, LE; Schicha, H; Siebers, G; Vyska, K, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rouf, R | 1 |
| Greytak, S | 1 |
| Wooten, EC | 1 |
| Wu, J | 1 |
| Boltax, J | 1 |
| Picard, M | 1 |
| Svensson, EC | 1 |
| Dillmann, WH | 1 |
| Patten, RD | 1 |
| Huggins, GS | 1 |
| Mishra, P | 1 |
| Samanta, L | 1 |
| Van Vleet, JF | 1 |
| Ferrans, VJ | 1 |
| Badylak, SF | 1 |
| Jeevanandam, V | 1 |
| Jamall, IN | 1 |
| Pagel, PS | 1 |
| Hettrick, DA | 1 |
| Lowe, D | 1 |
| Kersten, JR | 1 |
| Tessmer, JP | 1 |
| Warltier, DC | 1 |
| Wu, HY | 1 |
| Xia, YM | 1 |
| Ha, PC | 1 |
| Chen, XS | 1 |
| Goichot, B | 1 |
| Schlienger, JL | 1 |
| Kako, KJ | 1 |
| Patterson, SD | 1 |
| Siebers, G | 1 |
| Schicha, H | 1 |
| Becker, V | 1 |
| Vyska, K | 1 |
| Feinendegen, LE | 1 |
| Tahiliani, AG | 2 |
| McNeill, JH | 2 |
| Ganguly, PK | 2 |
| Beamish, RE | 2 |
| Dhalla, KS | 2 |
| Innes, IR | 2 |
| Dhalla, NS | 2 |
| Cavallo, A | 1 |
| Casta, A | 1 |
| Fawcett, HD | 1 |
| Nusynowitz, ML | 1 |
| Wolf, WJ | 1 |
4 reviews available for triiodothyronine and Cardiomyopathies
| Article | Year |
|---|---|
Oxidative stress and heart failure in altered thyroid States.
Topics: Animals; Atherosclerosis; Cardiomyopathies; Coronary Artery Disease; Heart Defects, Congenital; Hear | 2012 |
Triiodothyronine: spectrum of use in heart transplantation.
Topics: Cardiomyopathies; Cardiopulmonary Resuscitation; Heart Transplantation; Humans; Tissue Donors; Triio | 1997 |
[Non-thyroid indications of treatment with thyroid hormones].
Topics: Animals; Cardiac Surgical Procedures; Cardiomyopathies; Cardiovascular System; Clinical Trials as To | 1998 |
Diabetes-induced abnormalities in the myocardium.
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Calcium; Carbohydrate Metabolism; Cardiomyopathie | 1986 |
1 trial available for triiodothyronine and Cardiomyopathies
| Article | Year |
|---|---|
Triiodothyronine: spectrum of use in heart transplantation.
Topics: Cardiomyopathies; Cardiopulmonary Resuscitation; Heart Transplantation; Humans; Tissue Donors; Triio | 1997 |
10 other studies available for triiodothyronine and Cardiomyopathies
| Article | Year |
|---|---|
Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription.
Topics: Animals; Cardiomyopathies; Cell Line; DNA-Binding Proteins; Echocardiography; Heart Failure; Humans; | 2008 |
Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs.
Topics: Alopecia; Animals; Cardiomyopathies; Dog Diseases; Dogs; Doxorubicin; Female; Heart; Melanosis; Myoc | 1982 |
Positive inotropic and lusitropic effects of triiodothyronine in conscious dogs with pacing-induced cardiomyopathy.
Topics: Animals; Cardiac Pacing, Artificial; Cardiomyopathies; Dogs; Hemodynamics; Injections, Intravenous; | 1997 |
Changes in myocardial thyroid hormone metabolism and alpha-glycerophosphate dehydrogenase activity in rats deficient in iodine and selenium.
Topics: Analysis of Variance; Animals; Cardiomyopathies; Energy Metabolism; Glycerolphosphate Dehydrogenase; | 1997 |
Phosphatidate phosphohydrolase and palmitoyl-coenzyme A hydrolase in cardiac subcellular fractions of hyperthyroid rabbits and cardiomyopathic hamsters.
Topics: Acid Phosphatase; Acyltransferases; Adenosine Triphosphatases; Animals; Cardiomyopathies; Cricetinae | 1975 |
[Minimal cardiac transit time in thyroid disorders and in the effort syndrome].
Topics: Adult; Blood Flow Velocity; Cardiomyopathies; Diagnosis, Differential; Female; Heart; Heart Failure; | 1975 |
Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment.
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Calcium; Cardiomyopathies; Diabetes Mellitus, Exp | 1985 |
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Half-Life; Insulin; Male; Myocardium; No | 1987 |
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy.
Topics: Adrenergic Fibers; Animals; Cardiomyopathies; Cold Temperature; Diabetes Mellitus, Experimental; Mal | 1986 |
Is there a thyrotoxic cardiomyopathy in children?
Topics: Adolescent; Blood Pressure; Cardiomyopathies; Child; Female; Heart Rate; Humans; Hyperthyroidism; Ma | 1985 |